A randomized comparative study on maintenance gemcitabine versus supportive care in pleural mesothelioma
Karam, Abanoub Samir; Abdelwahab, Sherif; Ezz El Din, Mai Mohamed Ali; Alorabi, Mohamed;
Abstract
Pleural mesothelioma (PM) is a rare aggressive cancer linked to asbestos exposure, with limited treatment options, especially in low-resource settings. While immune checkpoint inhibitors show promise, access remains limited in many countries.
Other data
| Title | A randomized comparative study on maintenance gemcitabine versus supportive care in pleural mesothelioma | Authors | Karam, Abanoub Samir; Abdelwahab, Sherif; Ezz El Din, Mai Mohamed Ali; Alorabi, Mohamed | Keywords | Pleural mesothelioma; gemcitabine; maintenance therapy; overall survival; platinum-pemetrexed; progression-free survival; resource-limited settings | Issue Date | Jul-2025 | Journal | Future oncology (London, England) | ISSN | 14796694 | DOI | 10.1080/14796694.2025.2516412 | PubMed ID | 40501447 | Scopus ID | 2-s2.0-105008755941 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.